| [1] |
Quirke P, Steele R, Monson J, et al.Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.Lancet, 2009, 373(9666): 821-828.
|
| [2] |
Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer.Swedish Rectal Cancer Trial.N Engl J Med, 1997, 336(14): 980-997.
|
| [3] |
Birqisson H, Pählman L, Gunnarsson U, et al.Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial.J Clin Oncol, 2005, 23(34): 8697-8705.
|
| [4] |
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.N Engl J Med, 2001, 345: 638-646.
|
| [5] |
Van Gijn W, Marijnen CA, Nagtegaal ID, et al.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.Lancet Oncol, 2011, 12: 575-582.
|
| [6] |
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al.Sphincter preservation following preoperative radiotherapy for rectal cancer: : report of a randomized trial comparing short-term radiotherapy vs.conventionally fractionated radiochemotherapy.Radiother Oncol, 2004, 72: 15-24.
|
| [7] |
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al.Long term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.Br J Surg, 2006, 93: 1215-1223.
|
| [8] |
Ngan SY, Burmeister B, Fisher RJ, et al.Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04Clin Oncol, 2012, 30: 3827-3833.
|
| [9] |
Sebag-Montefiore D, Stephens RJ, Steele R, et al.Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer(MRC CR07 and NCIC-CTG C016): a multicenter, randomised trial.Lancet, 2009, 373: 811-820.
|
| [10] |
Pettersson D, Cedermark B, Holm T, et al.Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer.Br J Surg, 2010, 97: 580-587.
|
| [11] |
Colette BM, van den Broeka, Thomas A, et al.Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients.Eur J of Cancer, 2013, 49: 3131-3139.
|
| [12] |
Van Dijk TH, Tamas K, Beukema JC, et al.Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer.Ann Oncol, 2013, 24: 1762-1769.
|
| [13] |
Robert J, Myerson, Parag J, et al.Effect of short course radiation followed by four cycles of FOLFOX as preoperative therapy for rectal cancer on rate of PCR: A phase II trial.J Clin Oncol, 2013, 30: 2145-2158.
|
| [14] |
Nilsson PJ, van Etten B, Hospers GA, et al.Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer-the RAPIDO trial.BMC Cancer, 2013, 13: 279.
|